Biomerica (BMRA) Net Cash Flow (QoQ) (2010 - 2026)
Biomerica (BMRA) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -133.60% |
| Nov 30, 2025 | -178.07% |
| Aug 31, 2025 | 197.90% |
| May 31, 2025 | -196.94% |
| Feb 28, 2025 | 186.85% |
| Nov 30, 2024 | 41.15% |
| Aug 31, 2024 | -25.84% |
| May 31, 2024 | 41.22% |
| Feb 29, 2024 | -112.76% |
| Nov 30, 2023 | 50.83% |
| Aug 31, 2023 | -127.26% |
| May 31, 2023 | 473.56% |
| Feb 28, 2023 | -70.60% |
| Nov 30, 2022 | -684.80% |
| Aug 31, 2022 | 104.03% |
| May 31, 2022 | -242.50% |
| Feb 28, 2022 | 247.69% |
| Nov 30, 2021 | -351.06% |
| Aug 31, 2021 | 174.77% |
| May 31, 2021 | -164.63% |